President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a ...

By Siddhi Mahatole May 4 (Reuters) - Aesthetic firms are betting that a growing pool of patients experiencing loose skin and ...

U.S. President Donald Trump announced on Friday that the federal government is taking steps to expand access to GLP-1 ...

Obesity assets represent about 25% of total forecast sales of the late-stage pipeline, while oncology's share has slipped to ...

Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and Drug ...

GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and ...

A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity ...

After just a few weeks on the market, thousands are already on Foundayo, Eli Lilly's oral weight loss pill. The drugmaker is ...

Eli Lilly shares jumped after the drugmaker posted earnings that topped estimates and hiked its outlook, thanks to booming ...